IGI Laboratories (IG) to Release Earnings on Tuesday

Share on StockTwits

IGI Laboratories (NYSE:IG) will be releasing its earnings data on Tuesday, April 29th. Investors interested in registering for the company’s conference call can do so using this link.

IGI Laboratories (NYSE:IG) last posted its quarterly earnings results on Thursday, February 27th. The company reported ($0.01) EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.01 by $0.02. On average, analysts expect IGI Laboratories to post $0.03 EPS for the current fiscal year and $0.15 EPS for the next fiscal year.

Shares of IGI Laboratories (NYSE:IG) opened at 4.91 on Monday. IGI Laboratories has a 1-year low of $1.24 and a 1-year high of $6.14. The stock has a 50-day moving average of $5.03 and a 200-day moving average of $3.53. The company’s market cap is $230.9 million. IGI Laboratories also was the recipient of a large growth in short interest in April. As of April 15th, there was short interest totalling 279,070 shares, a growth of 79.4% from the March 31st total of 155,561 shares. Currently, 2.2% of the shares of the stock are sold short. Based on an average daily trading volume, of 272,377 shares, the short-interest ratio is currently 1.0 days.

On a related note, analysts at Craig Hallum initiated coverage on shares of IGI Laboratories in a research note on Monday, April 21st. They set a “buy” rating and a $7.50 price target on the stock.

IGI Laboratories, Inc (NYSE:IG) develops, manufactures, fills and packs topical semi-solid and liquid products for cosmetic, cosmeceutical and pharmaceutical customers.

Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.

Latest News

VimpelCom Ltd Upgraded by Zacks to “Neutral”
VimpelCom Ltd Upgraded by Zacks to “Neutral”
Hyster-Yale Materials Handling Given New $96.00 Price Target at Robert W. Baird
Hyster-Yale Materials Handling Given New $96.00 Price Target at Robert W. Baird
Investec Upgrades Debenhams Plc to “Hold”
Investec Upgrades Debenhams Plc to “Hold”
Goldman Sachs Rating Reiterated by Macquarie
Goldman Sachs Rating Reiterated by Macquarie
Insider Selling: Mead Johnson Nutrition CO Director Unloads 10,000 Shares of Stock
Insider Selling: Mead Johnson Nutrition CO Director Unloads 10,000 Shares of Stock
Insider Selling: Philip G. Franklin Sells 3,400 Shares of Littelfuse Stock
Insider Selling: Philip G. Franklin Sells 3,400 Shares of Littelfuse Stock


Leave a Reply

 
© 2006-2014 Mideast Time.